Rab Pharma

Mounjaro 2.5mg Solution for Injection is administered once weekly subcutaneously in the abdomen, thigh, or upper arm. To maximize its benefits, maintain a consistent injection schedule and complement treatment with a healthy diet and regular exercise. Follow your doctor’s instructions carefully, including any dose adjustments, and store the medication properly in the refrigerator.

Common side effects of Mounjaro 2.5mg Solution for Injection include nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are typically mild and improve over time. If they become severe or persistent, consult a doctor. They can help by adjusting the dose or suggesting ways to prevent them. Drinking plenty of water and staying hydrated may also help reduce discomfort from gastrointestinal symptoms.

Mounjaro 2.5mg Solution for Injection should not be used by individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). Pregnant individuals or those planning to become pregnant should avoid this medicine as it may cause harmful effects on the developing baby. Before taking this medicine, inform your doctor about all the other medicines you are taking to avoid interaction.

Mounjaro 2.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 2.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 2.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 2.5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 12.5mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.

Mounjaro 7.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 7.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 7.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 7.5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 7.5mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.

This injection is used for Type 2 Diebetis mostly it helps to controll your cravings then the ut come is weight loss

It can help to loose weight up 1-5 kgs per dosage

It should be taken 1 dose of 0.5 ml per weak

Remarks: Those who are not sufferrring from diebeties should maintain their insulin level by taking glucose in their diet to avoid naushia or tiredness after injecting it

***Note: please take every dose in observation of the medidical practitioner

This injection is used for Type 2 Diebetis mostly it helps to controll your cravings then the ut come is weight loss
It can help to loose weight up 1-5 kgs per dosage
It should be taken 1 dose of 0.5 ml per weak
Remarks: Those who are not sufferrring from diebeties should maintain their insulin level by taking glucose in their diet to avoid naushia or tiredness after injecting it
***Note: please take every dose in observation of the medidical practitioner

This injection is used for Type 2 Diebetis mostly it helps to controll your cravings then the ut come is weight loss
It can help to loose weight up 1-5 kgs per dosage
It should be taken 1 dose of 0.5 ml per weak
Remarks: Those who are not sufferrring from diebeties should maintain their insulin level by taking glucose in their diet to avoid naushia or tiredness after injecting it
***Note: please take every dose in observation of the medidical practitioner

This injection is used for Type 2 Diebetis mostly it helps to controll your cravings then the ut come is weight loss
It can help to loose weight up 1-5 kgs per dosage
It should be taken 1 dose of 0.5 ml per weak
Remarks: Those who are not sufferrring from diebeties should maintain their insulin level by taking glucose in their diet to avoid naushia or tiredness after injecting it
***Note: please take every dose in observation of the medidical practitioner

Victoza (liraglutide) is commonly used to help lower blood sugar levels in people with type 2 diabetes. Victoza is used to lower the risk of cardiovascular events (heart attack, stroke, or death) in people who have type 2 diabetes and heart disease.

Mounjaro 12.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 12.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 12.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 12.5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 12.5mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.

Mounjaro 10 mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 12.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 10 mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 10 mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 10 mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.

Mounjaro 5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 5mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.

This injection is used for Type 2 Diebetis mostly it helps to controll your cravings then the ut come is weight loss

It can help to loose weight up 1-5 kgs per dosage

It should be taken 1 dose of 0.5 ml per weak

Remarks: Those who are not sufferrring from diebeties should maintain their insulin level by taking glucose in their diet to avoid naushia or tiredness after injecting it

***Note: please take every dose in observation of the medidical practitioner

Lirafit (liraglutide) injection is used to manage type 2 diabetes and promote weight loss. It is a prescription medication that works by regulating blood sugar levels and controlling appetite. 

For type 2 diabetes

Lirafit is prescribed for adults and children over 10 with type 2 diabetes, typically when diet, exercise, and other medications are insufficient to control blood sugar levels. It can help to: 

Lower blood sugar: It stimulates the pancreas to release more insulin after a meal and reduces the amount of sugar the liver produces.

Slow down digestion: It slows gastric emptying, which helps prevent a rapid spike in blood sugar after eating.

Reduce cardiovascular risk: In adults with type 2 diabetes and existing heart or blood vessel disease, it is used to lower the risk of major cardiovascular events, such as heart attack and stroke.

Prevent complications: By helping to control blood sugar, it reduces the risk of serious diabetes complications like kidney damage and blindness. 

For weight management

Lirafit is also used as part of a comprehensive weight-loss program that includes a reduced-calorie diet and increased physical activity. It aids in weight loss by: 

Regulating appetite: It promotes a feeling of fullness and decreases appetite, which helps patients reduce their calorie intake.

Slowing digestion: The slower emptying of the stomach further contributes to a feeling of satiety. 

Trulicity is an injectable diabetes medicine that helps control blood sugar levels. Trulicity is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

Mounjaro 15mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 12.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 15mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 15mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 15mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.